 Home > Active Ingredient News > Antitumor Therapy > International Cancer Research Organization IARC: HPV vaccination for girls of school age in my country will reduce more than 90% of cervical cancer patients!

International Cancer Research Organization IARC: HPV vaccination for girls of school age in my country will reduce more than 90% of cervical cancer patients!

 Last Update: 2021-04-22
 Source: Internet
 Author: User

Tags

merck cancer drug

breast cancer receptors

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Cervical cancer is the fourth most common cancer among women in the world and the largest source of cancer-related mortality among women in sub-Saharan Africa.

HPV vaccination programs to prevent infection have proven to be cost-effective across a wide range of worlds.

However, different regions face multiple obstacles in including HPV vaccination as part of their national expanded immunization plans.

Immune to COVID-19

Therefore, as of 2019, only 96 countries (mostly high-income countries) have introduced the vaccine.

In many countries, the coverage of HPV vaccine among girls of school-age age is far from reaching the standards recommended by the World Health Organization (WHO)-90% of girls complete HPV vaccination before the age of 15.

To this end, the WHO launched an initiative to eliminate the public health problem of cervical cancer.

The results show that globally, if vaccination is not carried out, it is estimated that by 2094, the burden of cervical cancer in women aged 6-15 (that is, born in 2005-2014) will reach 11.

At present, the burden of cervical cancer in women aged 6-15 (that is, born in 2005-2014) will reach 11.

At present, there are nearly 80 million girls of school-age age in China.

The researchers further found that if the nine-valent HPV vaccine is vaccinated to increase the prevention of HPV types 31, 33, 45, 52, and 58, the number of preventable cervical cancer cases worldwide will increase to 10.

If so , increase the prevention of HPV types 31, 33, 45, 52, 58, and the number of preventable cervical cancer cases worldwide will increase to 10.

In summary, the study provides a detailed estimate of the increasing burden of cervical cancer and the expected impact of HPV vaccination, which has direct implications for public health decision makers.

The study provides a detailed estimate of the increasing burden of cervical cancer and the expected impact of HPV vaccination, which has direct implications for public health decision makers.

references:

Global estimates of expected and preventable cervical cancers among girls born between 2005 and 2014: a birth cohort analysis.

Global estimates of expected and preventable cervical cancers among girls born between 2005 and 2014: a birth cohort analysis.
Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.